Navigation Links
Research highlights new approaches to prevent blood clots
Date:12/6/2008

ct was measured after a 30-minute intravenous infusion of avidin (100 mg), a hen egg protein that binds with biotin to reverse the Factor Xa inhibiting activity of idrabiotaparinux. At the end of the initial six-month treatment with idrabiotaparinux, a subset of patients was re-randomized to receive avidin (those in the idrabiotaparinux arm) or placebo (those in both the idrabiotaparinux and idraparinux arms to preserve blinding). Avidin or placebo was infused between two and five hours after the last injection of idrabiotaparinux or idraparinux.

Anti-Factor Xa activity was measured just prior to the infusion, just after the infusion, and then every day for five days to ensure that the reversibility remained unchanged.

The study found that there was less clinically relevant bleeding (5.2 percent versus 7.3 percent) and less major bleeding (0.8 percent versus 3.8 percent) in those treated with idrabiotaparinux as compared with idraparinux. Rates of recurrent venous thromboembolism (2.3 percent versus 3.2 percent) and fatal or non-fatal pulmonary embolism (1.6 percent versus 1.8 percent) were similar with both idrabiotaparinux and idraparinux.

Levels of Factor Xa activity were identical in both treatment groups throughout the six-month study. Of the 52 idrabiotaparinux patients re-randomized to receive avadin or placebo, 41 were analyzed for reversal of Factor Xa activity (23 received avidin and 18 received placebo). At the end of the 30-minute infusion of avidin, mean anti-Factor Xa activity was reduced by 77.8 percent and was sustained for at least five days as compared with 2.4 percent for the placebo group. The infusion of avidin was well-tolerated with no allergic reactions observed.

Randomized, Parallel Group, Multicenter, Multinational Study Evaluating Safety of DU-176b Compared With Warfarin in Subjects With Non-Valvular Atrial Fibrillation [Abstract #33]
Jeffrey I. Weitz, MD, Henderson Researc
'/>"/>

Contact: Laura Stark
lstark@hematology.org
415-978-3505
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. 50 years of hairy-cell leukemia research to be observed
2. Event Honoring Bill Gates Raises Over $1.5 Million for Sustainable Agriculture Research at The Hebrew University of Jerusalem
3. New Research Reports on Interventions that May Alter the Course of Epilepsy Diagnosis and Management
4. Researchers & Department of Defense Question Multiple Vaccine Administration
5. Researchers gain new insight on wonder of cell division
6. HALT-C researchers: Interferon as long-term treatment for hepatitis C not effective
7. Jefferson researcher awarded NIH grant
8. Researcher develops screening tool to identify patients with prediabetes
9. Partnership for Peak Healthcare Performance Research Shows Consumers Lack Involvement in Managing Their Health
10. Nestle Launches New Research Program on the Specific Nutritional Needs of Athletes
11. LA BioMed researchers among Southern California Super Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... time to deploy Ebola vaccines is now, Free ... now, according to a commentary being published early online ... . The authors from Yale School of Public Health ... of the current Ebola outbreak represent a public health ... efforts. Several Ebola vaccines have been developed in the ...
(Date:8/20/2014)... Barbara Bronson Gray ... -- Although it,s extremely rare, colds, flu and other ... elevated risk for stroke in children, a new study suggests. ... a stroke in the United States, said Dr. Heather Fullerton, ... and pediatrics at the University of California, San Francisco Benioff ...
(Date:8/20/2014)... Steven Reinberg HealthDay ... The speed at which cancer cells grow may help doctors ... Using this measure, investigators have found that the deadliest ... of older men with a long history of sun exposure. ... the researchers discovered. Rapid cell growth -- called ...
(Date:8/20/2014)... 2014 Park Cities Pet Sitter , ... 4 Pets supply donation drive that benefits the animal shelter ... campaign that coincides with the Humane Society of the United ... through 8th, 2014. , As part of their participation, Park ... monetary donations for the Presents 4 Pets drive from their ...
(Date:8/20/2014)... to spawning grounds through fast-moving waters may be at ... scientists. , When salmon encounter turbulent, fast-moving water ... they must move upstream using a behaviour known as ... , "Days after sockeye passed through extremely fast-moving water, ... distance from their spawning grounds," said Nicholas Burnett, a ...
Breaking Medicine News(10 mins):Health News:News from Annals of Internal Medicine 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 2Health News:High-Risk Melanomas Often on Head or Neck, Study Finds 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 2Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 3Health News:Dallas-based Park Cities Pet Sitter Announces Participation in the 2014 National Association of Professional Pet Sitters “Presents 4 Pets” Program 4Health News:Salmon forced to 'sprint' less likely to survive migration 2
... of Sciences Leopoldina honored ASU Foundation Professor Bert ... part of the opening ceremonies of the Leopoldina,s ... Hlldobler is highly-regarded, internationally-recognized behavioral scientist ... organization in insects. Ants in particular have served ...
... to perform everyday activities. This is not primarily due to ... was previously believed new research from the University of ... initiate and complete a task towards a specific goal. ... normally results in a degree of paralysis in the lower ...
... A team of researchers from Boston University,s School of ... awarded a five-year, $4.8 million National Institutes of Health ... platform. Based on technologies developed with seed funding ... should be capable of rapidly detecting - at the ...
... high-risk non-melanoma skin carcinomas of the head and neck ... a UNC-led study. Their study is the first to ... simultaneously with radio-and chemotherapy. Scientists with the UNC ... Sept. 26, 2011 online issue of the International ...
... -- The use of long-distance video and data hookups to ... provides the same level of care as having everyone in ... at the Canadian Stroke Congress. The study found that ... Telestroke received an important stroke drug, tPA, at the same ...
... By Serena Gordon HealthDay Reporter , MONDAY, ... linked to the sexually transmitted human papillomavirus (HPV) rose dramatically ... Within a decade, these types of tumors might become the ... the period between 1984 and 1989, just 16.3 percent of ...
Cached Medicine News:Health News:Cothenius Medal awarded to Arizona State University social insect scientist for life's work 2Health News:Cothenius Medal awarded to Arizona State University social insect scientist for life's work 3Health News:Cothenius Medal awarded to Arizona State University social insect scientist for life's work 4Health News:Children with spina bifida need personal 'starter' 2Health News:Researchers from Boston University receive grant to develop improved virus detection system 2Health News:Combination therapy beneficial for head and neck skin carcinomas, UNC study shows 2Health News:Telestroke the next best thing 2Health News:HPV-Linked Oral Cancers on the Rise, Study Finds 2Health News:HPV-Linked Oral Cancers on the Rise, Study Finds 3
(Date:8/20/2014)... Research and Markets has ... Market (Technology, Types, Applications, Services and Geography) - ... their offering. A new report ... - Size, Share, Global Trends, Company Profiles, Demand, ... 2013 - 2020", suggests that the global biosimilars ...
(Date:8/20/2014)... 20, 2014 Research and Markets  has announced ... report to their offering. Global Market ... on Pralmorelin globally and regionally ( Europe , ... , Latin America etc.). It captures ... This report focuses on three primary areas; manufacture methods & ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com announces ... in its catalogue: Global Coatings for ... This report analyzes the ... US$ Million by the following Product Segments: Active ... The report provides separate comprehensive analytics for the ...
Breaking Medicine Technology:Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2Global Market Report of Pralmorelin 2Global Coatings for Medical Devices Industry 2Global Coatings for Medical Devices Industry 3Global Coatings for Medical Devices Industry 4Global Coatings for Medical Devices Industry 5Global Coatings for Medical Devices Industry 6Global Coatings for Medical Devices Industry 7Global Coatings for Medical Devices Industry 8Global Coatings for Medical Devices Industry 9Global Coatings for Medical Devices Industry 10Global Coatings for Medical Devices Industry 11Global Coatings for Medical Devices Industry 12Global Coatings for Medical Devices Industry 13Global Coatings for Medical Devices Industry 14Global Coatings for Medical Devices Industry 15Global Coatings for Medical Devices Industry 16Global Coatings for Medical Devices Industry 17Global Coatings for Medical Devices Industry 18Global Coatings for Medical Devices Industry 19Global Coatings for Medical Devices Industry 20Global Coatings for Medical Devices Industry 21
... Dec. 29, 2010 Reportlinker.com announces that a ... catalogue: The Market for Pharmaceuticals ... http://www.reportlinker.com/p0203101/The-Market-for-Pharmaceuticals-in-Brazil-Russia-India--China.html Evaluate the ... Brazil, Russia, India and China now and in ...
... Dec. 29, 2010 Centocor Ortho Biotech Inc. announced ... Application (sBLA) with the U.S. Food and Drug Administration ... treatment of moderately to severely active ulcerative colitis (UC) ... to conventional therapy.  REMICADE was designated orphan drug status ...
Cached Medicine Technology:Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 2Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 3Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 4Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China 5Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 2Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 3Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 4Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 5Centocor Ortho Biotech Inc. Submits Application to FDA Seeking REMICADE® Pediatric Ulcerative Colitis Indication 6
Inquire...
Inquire...
Contour I pouches are light as a feather and feature our tapered SoftFlex skin barrier for comformability, flexbility and comfort. All Contour I pouches have ComfortWear panels that keep skin cool an...
Inquire...
Medicine Products: